Novo Nordisk, maker of weight-loss drug Wegovy, struck a deal with online telehealth storefronts that sold cheap knockoffs during shortages.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
The drug-store chain lowered prices on more than 1,500 items including vitamins, chips, lotion, and Squishmallow plushies.
Ford filed two patents to make EV charging adoption quicker, cheaper and easier.
Toyota is partnering with petroleum firms to develop carbon-neutral fuels and make them available in Japan by 2030.
Reducing beverage-wait times is part of Starbucks CEO Brian Niccol’s turnaround plan, which includes tech updates focused on efficiency.
IBM’s patent aims to use self-driving cars’ idle resources, giving access to them to the riders within them.
Just what, exactly, would Sony and Apollo Global Management be getting out of a Paramount Global acquisition?
If 3 million people pass through security checkpoints Friday, it’d mark the busiest travel day ever recorded.
To prepare for a slowdown of global trade, US retailers spent months building a massive inventory to prevent empty shelves.
In an era when seemingly every tech company is vying to win the AI race, power has become the name of the game.
The retailer will cut prices on up to 5,000 grocery items to keep pace with lower-cost rivals like Walmart.
A loophole lets the company create a back-door offering of a generic drug before the patents of Novo Nordisk and Eli Lilly expire.
Canada’s Liberal Party won a majority promising to distance the country from the US, a major importer of Canadian crude.
Investor worries about a fresh batch of US tariffs have dragged LVMH shares in Paris down 23.6% so far this year.
The company plans to seek regulatory approval for the revolutionary weight loss treatment by the end of the year.
The warnings come as the industry adapts to seismic shifts in technology — which means it may just have some new tricks up its sleeve.